You are viewing: North America Blood Glucose Monitor Market analysis
Part of: Blood Glucose Monitor Market (Global)

The North America Blood Glucose Monitor Market was valued at $6519.5 Million in 2025 and projected to reach to $9929.2 Million by 2030, representing a compound annual growth rate of 8.8%. North America's blood glucose monitor market is poised for steady growth driven by the region's mature healthcare infrastructure, high prevalence of Type 1 and Type 2 diabetes, and increasing adoption of continuous glucose monitoring systems.

North America Blood Glucose Monitor Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Blood Glucose Monitor Market Trends and Insights

  • North America's mature healthcare infrastructure and high prevalence of diabetes drive sustained demand for glucose monitoring devices across the region.
  • In North America, increasing adoption of continuous glucose monitors (CGMs) and digital health integration are reshaping the competitive landscape. North America benefits from strong regulatory frameworks, advanced reimbursement policies, and a tech-savvy patient population that accelerates innovation adoption.
  • The region's aging demographic and rising obesity rates continue to expand the patient base requiring glucose monitoring solutions.
  • Between 2025 and 2030, North America is expected to maintain its position as a key revenue generator, supported by ongoing product launches and strategic partnerships among leading manufacturers..

Key Market Statistics

  • CAGR (2025-2030) 8.8% CAGR
  • Market Size, 2025 ~USD 6519.5 Million
  • Forecast, 2030 ~USD 9929.2 Million
  • Geography North America

North America Blood Glucose Monitor Market Overview

Market Size & Growth :

North America's blood glucose monitor market is valued at $6,519.5 million in 2025 and is projected to reach $9,929.2 million by 2030, growing at a CAGR of 8.8%, slightly below the global average of 9.1%.

US Market Dominance :

The United States represents the largest market segment in North America with $3,681.7 million in 2025, accounting for approximately 56% of the regional market and driving innovation in glucose monitoring technology.

CGM Adoption Surge :

Continuous glucose monitoring (CGM) devices are experiencing rapid adoption across North America due to improved reimbursement policies, increased insurance coverage, and growing patient preference for real-time glucose tracking solutions.

Mature Healthcare Infrastructure :

North America's advanced healthcare systems, high diabetes prevalence, and strong digital health integration create a favorable environment for sustained demand and premium glucose monitoring device adoption.

North America Blood Glucose Monitor Market Dynamics

  • The market benefits from strong reimbursement frameworks, robust regulatory support, and significant investment in digital health technologies that enhance patient outcomes and disease management. Key growth drivers include rising diabetes awareness campaigns, integration of glucose monitors with mobile health platforms, and expanding insurance coverage for advanced monitoring devices.
  • The region's aging population and emphasis on preventive healthcare further support market expansion.
  • North America is expected to maintain its position as a premium market segment, with consumers increasingly adopting connected and AI-enabled glucose monitoring solutions that provide personalized insights and improved glycemic control..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • North America's blood glucose monitor market will grow from $6,519.5M (2025) to $9,929.2M (2030) at an 8.8% CAGR.
    • North America's advanced healthcare infrastructure and high diabetes prevalence support consistent market expansion.
    • Continuous glucose monitors and digital health integration are accelerating adoption rates across North America.
    • North America's favorable reimbursement environment and aging population drive long-term growth through 2030.

    Blood Glucose Monitor Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment NON-INVASIVE PRODUCTS (Product Type)
    Forecast Period 2025–2030
    Growth Rate CAGR of 9.1% from 2025 to 2030
    Largest Segment DIABETES MANAGEMENT (Application)
    Market Size Base Year (Billions) ~USD 16.44 (2025)
    Revenue Forecast (Billions) ~USD 25.41 (2030)
    Segments Covered Product Type, Type, Test Site, Application, End User

    North America Blood Glucose Monitor Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Product Type

    • Continuous Glucose Monitoring Systems
    • Non-Invasive Products
    • Professional Point-Of-Care Devices
    • Self-Monitoring Blood Glucose Systems

    By Type

    • Glucometers
    • Implants
    • Lancets & Lancing Devices
    • Sensors
    • Testing Strips
    • Transmitters & Receivers
    • Type 1 Diabetes
    • Type 2 Diabetes

    By Test Site

    • Fingertip
    • Other Test Sites
    • Upper Arm

    By Application

    • Diabetes Management
    • Health & Wellness Monitoring
    • Other Applications

    By End User

    • Hospitals & Clinics
    • Other End Users
    • Self/Home Care

    Target Audience

    • Medical Device Manufacturers : Manufacturers need North America-specific market data to develop competitive glucose monitoring products, understand regional regulatory requirements, and identify opportunities for CGM innovation and market penetration.
    • Healthcare Providers & Hospitals : Healthcare systems require market insights to optimize glucose monitoring device procurement, evaluate reimbursement trends, and implement evidence-based diabetes management protocols across North American facilities.
    • Pharmaceutical & Diagnostics Companies : Companies need regional market intelligence to align glucose monitoring solutions with diabetes treatment portfolios, understand payer landscapes, and develop integrated care delivery models in North America.
    • Investment & Private Equity Firms : Investors require detailed North American market analysis to identify acquisition targets, assess growth potential in the glucose monitoring sector, and evaluate portfolio company performance against regional benchmarks.
    • Healthcare Consultants & Analysts : Consultants need comprehensive North American market data to advise clients on market entry strategies, competitive positioning, reimbursement optimization, and long-term business planning in the glucose monitoring space.

    Key Companies in the North America Blood Glucose Monitor Market

    CompanyHQOwnershipStrongest segments
    KINDRED HEALTHCARE INC.United StatesPrivate CompanyLong-term acute care hospitals (LTACHs) – drug-intensive episodes,Inpatient rehabilitation facilities (IRFs) – rehab with chronic comorbidities,Contract rehabilitation and ancillary services,
    ABBOTT LABORATORIESUnited StatesPublic CompanyMedical Devices,Diagnostic Products,Nutritional Products,
    DEXCOM, INC.United StatesPublic CompanyDexcom G7 and G7 15 Day,Dexcom G6,Dexcom ONE and ONE+,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
    SINOCAREChinaPublic CompanyBlood glucose monitoring systems and strips,Blood pressure and multiparameter testing devices,Hospital and primary healthcare diagnostic solutions,
    I-SENS, INC.South KoreaPublic CompanyBlood glucose meters and strips (human),POCT systems (blood gas, electrolytes, coagulation),Veterinary diagnostics,
    NIPROJapanPublic CompanyDialysis products and services,Injection and infusion / hospital disposables,Pharmaceuticals (generics and kits),
    NEMAURA MEDICAL INC.United StatesPublic CompanysugarBEAT non-invasive CGM,proBEAT wellness and coaching programs,Diabetes prevention and reversal services,
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,

    KINDRED HEALTHCARE INC.

    Kindred Healthcare Inc. is a private healthcare company founded in 1985 and headquartered in the United States. With 64,200 employees, the company operates as a major provider of healthcare services across the nation.

    ABBOTT LABORATORIES

    Abbott Laboratories is a public company founded in 1888 and based in the United States. With 115,000 employees, it operates as a diversified healthcare and diagnostics company with a global presence.

    DEXCOM, INC.

    Dexcom, Inc. is a publicly traded company founded in 1999 and headquartered in the United States. The company employs 11,050 people and specializes in continuous glucose monitoring technology.

    MEDTRONIC

    Medtronic is a public company founded in 1949 and based in Ireland. With 95,000 employees, it is a global leader in medical technology and device manufacturing.

    SINOCARE

    Sinocare is a publicly traded company founded in 2002 and headquartered in China. The company employs 5,010 people and operates in the healthcare and medical device sector.

    I-SENS, INC.

    I-SENS, Inc. is a publicly traded company founded in 2000 and based in South Korea. The company employs 887 people and operates in the medical device and diagnostics industry.

    NIPRO

    Nipro is a publicly traded company founded in 1947 and based in Japan. With 38,593 employees, it manufactures medical devices and pharmaceutical products for global markets.

    NEMAURA MEDICAL INC.

    Nemaura Medical Inc. is a publicly traded company founded in 2009 and headquartered in the United States. With 36 employees, the company develops wearable medical technology solutions.

    TERUMO CORPORATION

    Terumo Corporation is a publicly traded company founded in 1921 and based in Japan. With 30,591 employees, it manufactures and distributes medical devices and blood products globally.

    North America vs. other regions

    HowNorth America compares to the other 3 regional blocs covered in this market.

    Europe
    ~USD 6848 Million · 7.6% wtd CAGR ·
    Asia Pacific
    ~USD 5855.6 Million · 11.2% wtd CAGR ·
    Middle East & Africa
    ~USD 490.8 Million · 10.2% wtd CAGR ·
    Latin America
    ~USD 1791.5 Million · 9.5% wtd CAGR ·

    Countries within North America - compare and drill down

    Country2025 size (native)
    USUSD 3681.7 Million
    CanadaUSD 275.9 Million

    Country market size visualization

    US
    USD 3681.7 Million
    Canada
    USD 275.9 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into North America's blood glucose monitor market with country-level breakdowns for the US and Canada, enabling precise market targeting and localized business strategy development.
    • Growth Trajectory Analysis : Understand the 8.8% CAGR growth pattern from 2025-2030, identifying key inflection points and market expansion opportunities specific to North American healthcare dynamics and consumer behavior.
    • Competitive Landscape Intelligence : Access North America-specific competitive positioning, reimbursement trends, and regulatory environment analysis to inform product development, market entry, and partnership strategies in this premium market segment.
    • Technology Adoption Trends : Discover North America's leading adoption of continuous glucose monitoring, digital health integration, and connected devices, providing insights into future market demands and innovation priorities.
    • Investment & Expansion Guidance : Make informed investment decisions with comprehensive North American market data, identifying high-growth segments, underserved patient populations, and optimal geographic expansion opportunities.

    Frequently asked questions

    What is the projected market size for blood glucose monitors in North America by 2030?

    North America's blood glucose monitor market is projected to reach $9,929.2 million by 2030, up from $6,519.5 million in 2025.

    What is the CAGR for the North America blood glucose monitor market?

    North America's blood glucose monitor market is expected to grow at a compound annual growth rate of 8.8% between 2025 and 2030.

    What factors are driving growth in North America's blood glucose monitor market?

    North America's market growth is driven by high diabetes prevalence, aging demographics, advanced healthcare infrastructure, favorable reimbursement policies, and increasing adoption of continuous glucose monitors.

    How does North America's market compare to global trends?

    North America's 8.8% CAGR is slightly below the global average of 9.1%, reflecting the region's mature market status and established healthcare systems.

    What technologies are shaping the North America blood glucose monitor market?

    North America is experiencing rapid adoption of continuous glucose monitors (CGMs), smartphone integration, cloud-based data management, and AI-driven analytics for personalized diabetes management.

    RESEARCH METHODOLOGY

    The study comprised four key activities to estimate the current size of the blood glucose monitor market. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step involved validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Top-down and bottom-up approaches were used to arrive at a comprehensive estimate of the overall market size. Finally, market breakdown and data triangulation techniques were utilized to determine the sizes of segments and subsegments within the market.

    Secondary Research

    The secondary research process involved extensive use of various secondary sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the blood glucose monitor market. It also helped obtain critical insights about key players in the industry, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.

    Primary Research

    In the primary research process, interviews were conducted with various sources from the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts were interviewed, including CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from prominent companies and organizations involved in the blood glucose monitor market. For the demand side, interviews were conducted with industry experts, purchase and sales managers, doctors, and personnel from research organizations. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.

    A breakdown of the primary respondents for the blood glucose monitor market is provided below:

    Blood Glucose Monitor Market

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the blood glucose monitor market includes the following details. The market sizing was undertaken from the global side.

    Country-level Analysis: The size of the blood glucose monitor market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall blood glucose monitor market was obtained from secondary data and validated by primary participants to arrive at the total blood glucose monitor market. Primary participants further validated the numbers.

    Geographic Market Assessment (By Region and Country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated by industry experts who were contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall blood glucose monitor market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Blood Glucose Monitor Market Size: Bottom-up Approach and Top-down Approach

    Blood Glucose Monitor Market

    Data Triangulation

    After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.

    Market Definition

    Blood glucose monitors are medical devices used to measure and monitor blood glucose (sugar) levels in individuals, primarily for the diagnosis and management of diabetes mellitus. These monitors help patients and healthcare professionals assess glycemic control, adjust treatment plans, and prevent diabetes-related complications.

    Stakeholders

    • Blood Glucose Monitor Manufacturers
    • Contract Manufacturers
    • Suppliers and Distributors of Blood Glucose Monitors
    • Senior Management
    • Finance Department
    • Healthcare Services Providers (Hospitals and Public & Private Clinics)
    • Academic & Research Institutes
    • E-commerce and Digital Platforms
    • Retail Pharmacies and Supermarkets
    • Trade Associations and Industry Bodies
    • Regulatory Bodies and Government Agencies
    • Business Research and Consulting Service Providers
    • Market Research and Consulting Firms
    • Venture Capitalists and Investors

    Report Objectives

    • To define, describe, segment, analyze, and forecast the global blood glucose monitor market by product type, application, test site, end user, and region.
    • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the blood glucose monitor market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
    • To profile the key players in the blood glucose monitor market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as agreements, collaborations, and partnerships; acquisitions; and product approvals & launches in the blood glucose monitor market.

    Get the Full Blood Glucose Monitor Market Report

    Full forecast, segment splits, and company analysis for all Blood Glucose Monitor Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status